Time course of MPTP toxicity on translational control protein expression in mice brain

Toxicology Letters

Volumn 196, Issue 1, 2010, Pages 51-55

  Deguil, Julie ^a   Chavant, François ^a,b   Lafay Chebassier, Claire ^a,b   Pérault Pochat, Marie Christine ^a,b   Fauconneau, Bernard ^a,b   Pain, Stéphanie ^a,b  

^a Research Group on Brain Aging   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Mice; MPTP; Parkinson; Translational control

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE R;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUBSTANTIA NIGRA; TRANSLATION REGULATION; WESTERN BLOTTING;

ANIMALS; BRAIN; EIF-2 KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEUROTOXINS; PROTEIN MODIFICATION, TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; TIME; TOXICITY TESTS;

MUS;

EID: 77952742947     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.03.1121     Document Type: Article

References (30)

1. Balachandran S., Kim C.N., Yeh W.C., Mak T.W., Bhalla K., Barber G.N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 1998, 17:6888-6902.
2. Bando Y., Onuki R., Katayama T., Manabe T., Kudo T., Taira K., Tohyama M. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 2005, 46:11-18.
3. Bruck A., Kurki T., Kaasinen V., Vahlberg T., Rinne J.O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2004, 75:1467-1469.
4. Chiba K., Trevor A., Castagnoli N. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 1984, 120:574-578.
5. Clemens M.J. Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins. J. Cell. Mol. Med. 2001, 5:221-239.
6. +-induced alteration of translational control in Neuro-2a neuroblastoma cells. J. Neurosci. Res. 2007, 85:2017-2025.
7. Deguil J., Chavant F., Lafay-Chebassier C., Pérault-Pochat M.C., Fauconneau B., Pain S. Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox. Res. 2010, 17:142-155.
8. Dufner A., Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell. Res. 1999, 253:100-109.
9. Gainetdinov R.R., Fumagalli F., Jones S.R., Caron M.G. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J. Neurochem. 1997, 69:1322-1325.
10. Gerlach M., Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 1996, 103:987-1041.
11. Gevaerd M.S., Miyoshi E., Silveira R., Canteras N.S., Takahashi R.N., Da Cunha C. L-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats. Int. J. Neuropsychopharmacol. 2001, 4:361-370.
12. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., Polakiewicz R.D., Wyslouch-Cieszynska A., Aebersold R., Sonenberg N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001, 15:2852-2864.
13. Gingras A.C., Raught B., Sonenberg N. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 2001, 27:143-174.
14. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., Hirsch E.C. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA 2000, 97:2875-2880.
15. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 2005, 94:215-225.
16. Malagelada C., Ryu E.J., Biswas S.C., Jackson-Lewis V., Greene L.A. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J. Neurosci. 2006, 26:9996-10005.
17. Miyoshi E., Wietzikoski S., Camplessei M., Silveira R., Takahashi R.N., Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Res. Bull. 2002, 58:41-47.
18. Mochizuki H., Goto K., Mori H., Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 1996, 137:120-123.
19. Paccalin M., Pain-Barc S., Pluchon C., Paul C., Bazin H., Gil R., Hugon J. The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease. Arch. Intern. Med. 2005, 165:2428-2429.
20. Paccalin M., Pain-Barc S., Pluchon C., Paul C., Besson M.N., Carret-Rebillat A.S., Rioux-Bilan A., Gil R., Hugon J. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2006, 22:320-326.
21. Proud C.G. Protein phosphorylation in translational control. Curr. Top. Cell. Regul. 1992, 32:243-369.
22. +. Biochem. Biophys. Res. Commun. 1986, 134:743-748.
23. Raught B., Gingras A.C., Sonenberg N. The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 2001, 98:7037-7044.
24. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 2002, 22:10690-10698.
25. Shen Y.Q., Hebert G., Lin L.Y., Luo Y.L., Moze E., Li K.S., Neveu P.J. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. J Neuroimmunol. 2005, 158:14-25.
26. Srivastava S.P., Kumar K.U., Kaufman R.J. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 1998, 273:2416-2423.
27. Tanila H., Bjorklund M., Riekkinen P. Cognitive changes in mice following moderate MPTP exposure. Brain. Res. Bull. 1998, 45:577-582.
28. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 2000, 166:29-43.
29. Tatton N.A., Kish S.J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 1997, 77:1037-1048.
30. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S.J., Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 2001, 98:2837-2842.